167 related articles for article (PubMed ID: 36160336)
1. Impact of bariatric surgery on circulating PCSK9 levels as a marker of cardiovascular disease risk: a meta-analysis.
Jamialahmadi T; Banach M; Almahmeed W; Kesharwani P; Sahebkar A
Arch Med Sci; 2022; 18(5):1372-1377. PubMed ID: 36160336
[TBL] [Abstract][Full Text] [Related]
2. Impact of Bariatric Surgery on Pulse Wave Velocity as a Measure of Arterial Stiffness: a Systematic Review and Meta-analysis.
Jamialahmadi T; Reiner Ž; Alidadi M; Kroh M; Simental-Mendia LE; Pirro M; Sahebkar A
Obes Surg; 2021 Oct; 31(10):4461-4469. PubMed ID: 34319469
[TBL] [Abstract][Full Text] [Related]
3. Effect of Bariatric Surgery on Flow-Mediated Vasodilation as a Measure of Endothelial Function: A Systematic Review and Meta-Analysis.
Jamialahmadi T; Alidadi M; Atkin SL; Kroh M; Almahmeed W; Moallem SA; Al-Rasadi K; Rodriguez JH; Santos RD; Ruscica M; Sahebkar A
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887817
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Bariatric Surgery on Circulating Levels of Oxidized Low-Density Lipoproteins Is Apparently Independent of Changes in Body Mass Index: A Systematic Review and Meta-Analysis.
Jamialahmadi T; Reiner Ž; Alidadi M; Kroh M; Cardenia V; Xu S; Al-Rasadi K; Santos RD; Sahebkar A
Oxid Med Cell Longev; 2021; 2021():4136071. PubMed ID: 34912496
[TBL] [Abstract][Full Text] [Related]
5. Effect of Bariatric Surgery on Intima Media Thickness: A Systematic Review and Meta-Analysis.
Jamialahmadi T; Reiner Ž; Alidadi M; Almahmeed W; Kesharwani P; Al-Rasadi K; Eid AH; Rizzo M; Sahebkar A
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294377
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis.
Jamialahmadi T; Abbasifard M; Reiner Ž; Kesharwani P; Sahebkar A
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498595
[No Abstract] [Full Text] [Related]
7. The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis.
Jamialahmadi T; Reiner Ž; Alidadi M; Kroh M; Almahmeed W; Ruscica M; Sirtori C; Rizzo M; Santos RD; Sahebkar A
Biomed Res Int; 2022; 2022():8435133. PubMed ID: 36033567
[TBL] [Abstract][Full Text] [Related]
8. Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials.
Sahebkar A; Simental-Mendía LE; Guerrero-Romero F; Golledge J; Watts GF
Diabetes Obes Metab; 2015 Nov; 17(11):1042-55. PubMed ID: 26183252
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of proprotein convertase subtilisin kexin type 9 are elevated by fibrate therapy: a systematic review and meta-analysis of clinical trials.
Sahebkar A
Cardiol Rev; 2014; 22(6):306-12. PubMed ID: 24614537
[TBL] [Abstract][Full Text] [Related]
10. Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment arms.
Sahebkar A; Di Giosia P; Stamerra CA; Grassi D; Pedone C; Ferretti G; Bacchetti T; Ferri C; Giorgini P
Br J Clin Pharmacol; 2016 Jun; 81(6):1175-90. PubMed ID: 26861255
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the impact of bariatric surgery on circulating TMAO levels as a predictor of cardiovascular disease risk.
Jamialahmadi T; Simental-Mendia LE; Zengin G; Almahmeed W; Kesharwani P; Sahebkar A
Curr Med Chem; 2023 May; ():. PubMed ID: 37226793
[TBL] [Abstract][Full Text] [Related]
12. Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients.
Zenti MG; Lupo MG; De Martin S; Altomari A; Galvan S; Aventaggiato M; Maneschi C; Sandri D; Paiola E; Battistoni M; Eccher A; Targher G; Bonora E; Ruscica M; Ferri N
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2372-2378. PubMed ID: 33028503
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk: An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials.
Mu G; Xiang Q; Zhou S; Liu Z; Qi L; Jiang J; Gong Y; Xie Q; Wang Z; Zhang H; Huo Y; Cui Y
Adv Ther; 2020 Apr; 37(4):1496-1521. PubMed ID: 32108309
[TBL] [Abstract][Full Text] [Related]
14. Bariatric Surgery Improves Serum CD40L Levels as a Predictor of Cardiovascular Risk: Systematic Review and Meta-analysis.
Jamialahamdi T; Eid AH; Nguyen NT; Gadde KM; Sukhorukov VN; Almahmeed W; Kroh M; Sahebkar A
Obes Surg; 2024 May; 34(5):1929-1937. PubMed ID: 38578522
[TBL] [Abstract][Full Text] [Related]
15. Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.
Simental-Mendía LE; Simental-Mendía M; Sánchez-García A; Banach M; Serban MC; Cicero AFG; Sahebkar A
Lipids Health Dis; 2019 Apr; 18(1):88. PubMed ID: 30954082
[TBL] [Abstract][Full Text] [Related]
16. Association of baseline LDL-C with total and cardiovascular mortality in patients using proprotein convertase subtilisin-kexin type 9 inhibitors: A systematic review and meta-analysis.
Khan SU; Riaz H; Rahman H; Khan MU; Khan MS; Alkhouli M; Kaluski E; Leucker TM; Blaha MJ
J Clin Lipidol; 2019; 13(4):538-549. PubMed ID: 31278046
[TBL] [Abstract][Full Text] [Related]
17. Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis.
Heffron SP; Parikh A; Volodarskiy A; Ren-Fielding C; Schwartzbard A; Nicholson J; Bangalore S
Am J Med; 2016 Sep; 129(9):952-9. PubMed ID: 26899751
[TBL] [Abstract][Full Text] [Related]
18. Acute and Chronic Impact of Bariatric Surgery on Plasma LDL Cholesterol and PCSK9 Levels in Patients With Severe Obesity.
Boyer M; Piché ME; Auclair A; Grenier-Larouche T; Biertho L; Marceau S; Hould FS; Biron S; Lebel S; Lescelleur O; Julien F; Martin J; Tchernof A; Carpentier AC; Poirier P; Arsenault BJ
J Clin Endocrinol Metab; 2017 Nov; 102(11):4023-4030. PubMed ID: 28938493
[TBL] [Abstract][Full Text] [Related]
19. Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity.
Kjellmo CA; Karlsson H; Nestvold TK; Ljunggren S; Cederbrant K; Marcusson-Ståhl M; Mathisen M; Lappegård KT; Hovland A
J Clin Lipidol; 2018; 12(1):193-202. PubMed ID: 29146227
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Jamialahmadi T; Baratzadeh F; Reiner Ž; Simental-Mendía LE; Xu S; Susekov AV; Santos RD; Sahebkar A
Mediators Inflamm; 2021; 2021():9661752. PubMed ID: 34526854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
